Emergence of Escherichia coli ST131 carrying carbapenemase genes, European Union/European Economic Area, August 2012 to May 2024

Euro Surveill. 2024 Nov;29(47):2400727. doi: 10.2807/1560-7917.ES.2024.29.47.2400727.

Abstract

Analysis of 594 isolates of Escherichia coli sequence type (ST)131 and its single locus variants carrying carbapenemase genes from 17 European Union/European Economic Area countries revealed acquisition of 18 carbapenemase variants, mainly in ST131 clades A and C. Most frequent were bla OXA-244 (n = 230) and bla OXA-48 (n = 224), detected in 14 and 12 countries, respectively. Isolates carrying bla OXA-244 have increased rapidly since 2021. The increasing detection of carbapenemase genes in the E. coli high-risk lineage ST131 is a public health concern.

Keywords: Carbapenem-resistant Enterobacterales; Escherichia coli; antibiotics; antimicrobial resistance; carbapenemase; cross-border spread; surveillance; whole genome sequencing.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Proteins* / genetics
  • Escherichia coli Infections* / epidemiology
  • Escherichia coli Infections* / microbiology
  • Escherichia coli Proteins / genetics
  • Escherichia coli* / genetics
  • Escherichia coli* / isolation & purification
  • Europe / epidemiology
  • European Union*
  • Humans
  • Microbial Sensitivity Tests
  • Multilocus Sequence Typing
  • beta-Lactamases* / genetics

Substances

  • beta-Lactamases
  • carbapenemase
  • Bacterial Proteins
  • Anti-Bacterial Agents
  • Escherichia coli Proteins